Periodic Reporting for period 1 - NANOTAM (Development and Evaluation of Nanomedicines for Cancer Treatment through Immunomodulation: Targeting Tumor-Associated Macrophages)

Recent clinical and experimental research establishes chronic inflammation and immune suppression as dominant effects in the tumor microenvironment. The infiltration of Tumor-Associated Macrophages (TAM) in tumor tissues has been shown to support tumor growth, invasion and...